Loading…
Kabra Drugs (BSE 524322)₹17.76+9.09%Pharmaceuticals
At the end of the Jun 2026 quarter, Kabra Drugs' shareholders were: public 100.00%. 0.00% of promoter shares were pledged. It had 9,678 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 7,414 | 7,395 | 7,363 | 7,335 | 7,366 | 7,342 | 7,434 | 7,448 | 8,097 | 8,860 | 9,183 | 9,678 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Kuniamuthur Nanjappan Anand | Public | 2.77% | 0.00 |
| Somisetty Malathi Latha | Public | 2.21% | −0.02 |
| Somisetty Giridhar Gupta | Public | 2.11% | 0.00 |
| Veeramreddy Vijay Kumar Reddy | Public | 1.93% | −1.35 |
| Chandraprakash Jamnalal Kabra | Public | 1.70% | 0.00 |
| Priyam Sachdeva | Public | 1.43% | +0.05 |
| Adusumilli Sai Raghava Pratap | Public | 1.35% | +0.21 |
| Narendra Babu Veerla | Public | 1.25% | 0.00 |
| Akilandeswari Selvamurthy | Public | 1.22% | 0.00 |
| Priyam Samir Shah | Public | 1.17% | −1.59 |
| Akansha Gupta | Public | 1.07% | 0.00 |
| Neha Sagar Shah | Public | 1.06% | 0.00 |
| Bosco Armando Menezes | Public | 1.04% | New |
| Shiva Kumar Adepu | Public | 1.04% | New |
| Rathna Pathengay | Public | 1.00% | New |
No. The Jun 2026 filing shows no pledged promoter shares.
Kabra Drugs had 9,678 shareholders at the end of the Jun 2026 quarter, against 7,448 a year earlier.
Kuniamuthur Nanjappan Anand (Public) held 2.77% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.